Patents by Inventor Martin J. McDermott

Martin J. McDermott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for production and use of mite group 1 proteins
    Patent number: 8465945
    Abstract: The present invention includes a method to produce a recombinant mite Group 1 protein in a methyltrophic yeast or an Escherichia coli microorganism. The present invention also relates to a recombinant mite Group 1 protein obtained by such a method, such a recombinant protein being able to selectively bind IgE or cause proliferation of a T cell that proliferate in response to a native mite Group 1 protein. Also included in the present invention is the use of such a recombinant mite Group 1 protein to detect mite allergy or to reduce an allergic response to a mite Group 1 protein. The present invention also includes novel mite Group 1 nucleic acid molecules, proteins, recombinant molecules, and recombinant cells, as well as uses thereof.
    Type: Grant
    Filed: October 2, 2006
    Date of Patent: June 18, 2013
    Assignee: Merck Patent GmbH
    Inventors: Elaine A. Best, Martin J. McDermott
  • Method and compositions for identifying anti-HIV therapeutic compounds
    Publication number: 20040121316
    Abstract: Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.
    Type: Application
    Filed: April 25, 2003
    Publication date: June 24, 2004
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Gabriel Birkus, James M. Chen, Xiaowu Chen, Tomas Cihlar, Eugene J. Eisenberg, Marcos Hatada, Gong-Xin He, Choung U. Kim, William A. Lee, Martin J. McDermott, Sundaramoorthi Swaminathan
  • Characterization of transfer factors and methods of use
    Patent number: 5883224
    Abstract: Characterization of transfer factors is provided in the form of amino acid and nucleic acid sequences corresponding to at least a portion of a conserved transfer factor region. The amino acid and nucleic acid sequences, or functional homologues thereof, are provided along with methods of use thereof for diagnostic, therapeutic and other purposes.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: March 16, 1999
    Assignee: Cytokine Sciences, Inc.
    Inventors: Charles H. Kirkpatrick, Martin J. McDermott, Stephen P. Eisenberg